JTEC Corporation of Osaka manufactures bio-technology systems and equipment. The Company produces life science devices, x ray mirrors, and automated cell culture systems. JTEC also develops pharmaceutical products. JTEC serves clients in Japan.

Consolidated Financial Results For The Three Months Ended September 30, 2025 [Japanese Gaap]

Consolidated Financial Results For The Fiscal Year Ended June 30, 2025 [Japanese Gaap]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

JTEC Corp/Osaka (3446 JP)

Consolidated Financial Results For The Three Months Ended September 30, 2025 [Japanese Gaap]

Consolidated Financial Results For The Fiscal Year Ended June 30, 2025 [Japanese Gaap]

Consolidated Financial Results For The Nine Months Ended March 31, 2025 [Japanese Gaap]

Consolidated Financial Results For The Three Months Ended December 31, 2024 [Japanese Gaap]

[Delayed] Consolidated Financial Results For The Three Months Ended September 30, 2024 [Japanese Gaap]

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)